# Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment

> **NCT04302402** · PHASE2 · UNKNOWN · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 132 (estimated)

## Conditions studied

- Dyspepsia

## Interventions

- **DRUG:** Rifaximin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04302402
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2021-03
- **Final completion:** 2023-03
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04302402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04302402, "Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04302402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*